Metabolism Disorder TRIZ Cases

Potassium citrate mediates interactions in high-fat protein emulsions, preventing sedimentation during sterilization while preserving caloric density.

Propionibacterium freudenreichii UF1 reduces body fat through induced thermogenesis and enhanced lipolysis, addressing obesity without high healthcare costs.

Povidone premixing isolates glimepiride from degrading conditions, lowering impurity levels to meet pharmaceutical stability standards.

Administering Nrg4 protein restores adipose-liver hormonal crosstalk, resolving the lack of effective tissue communication in metabolic disorders.

Isolating specific turmeric components resolves the contradiction between broad bioactivity and precise metabolic control.

Enzyme inactivation during supercritical CO2 extraction prevents enzymatic breakdown, preserving phospholipid quality and stability.

A selective kappa receptor antagonist normalizes blood glucose levels by restoring physiologic control of glucagon and insulin release.

Specific beta-alanine concentrations improve feed conversion ratio without reducing bodyweight gain.

Extracted VHH domains resolve murine antibody expression difficulties by enabling prokaryotic production while maintaining binding activity.

Combines DPP-4 inhibitor, proton pump inhibitor, and GABA to regenerate pancreatic beta-cells.

Active agent-conjugates utilize cysteine residues as linkers to attach therapeutic payloads while maintaining the native structural stability of the target antibody.

L-arginine buffers the formulation to suppress degradation of amino group-containing DPP-4 inhibitors, preserving chemical stability and dissolution profiles.

Spexin peptide regulates appetite via feedback loops to achieve permanent weight loss without genetic pathway disruption.

Oral indigestible galacto-oligosaccharides improve insulin sensitivity and prevent post-prandial glycaemic dips without cumbersome multiple dosages.

Encapsulating polyphenols in a protective bio-active agent prevents degradation during gut absorption, enabling synergistic SIRT1 up-regulation with NMN.

Modified carbon nanotubes deliver siRNA and DNA through intact plant cell walls, resolving the trade-off between transfection efficiency and cellular toxicity.

Enzyme treatment and parameter optimization increase Maysin and polyphenol content in sweet corn silk extract to enhance anti-obesity efficacy.

Red blood cells encapsulate phenylalanine hydroxylase to create stable bioreactors.

Color-changing hydrogel detects insulin leakage at the infusion site, preventing undetected dosing errors without adding electronic complexity.

Replacing NaCl with optimized excipients resolves chemical deterioration while maintaining resuspendability and uniform distribution.

High-affinity GDF15 antibodies resolve treatment specificity contradictions by inhibiting protein activity.

Marker-assisted selection introduces non-transgenic mutations to boost beta-conglycinin while avoiding low yield and lodging.

Measuring gingival crevicular fluid biomarkers enables early detection of gestational diabetes and preeclampsia before complications arise.

MicroRNA-30 reduces pro-inflammatory cytokine production by shifting adipose tissue macrophages from M1 to M2 phenotype.

Humanized anti-myostatin antibodies neutralize myostatin activity to treat muscle wasting disorders while minimizing side effects from cross-reactivity.

Novel meat-derived polypeptide combinations activate intestinal GLP-1 receptors to induce satiation and delay gastric emptying.

Co-administering C-peptide with insulin stimulates glucagon secretion and hepatic glucose production.

Segmented collagen tripeptides resolve the trade-off between therapeutic efficacy and side effects by targeting vascular aging without accumulation.

Novel celastrol derivatives resolve the trade-off between therapeutic efficacy and safety by reducing harmful side effects while improving glucose homeostasis.

Phospholipid-coated large lipid globules correct unbalanced growth trajectories and reduce obesity risk in infants born via Caesarean section.

A biomarker panel using CD169, AXL, CD271, and CD324 detects human dendritic cell precursors for subset-specific isolation.

A digestible polymer shell melts above body temperature to release active ingredients after a predetermined lag time.

Highly hydrophilic emulsifiers suppress foaming and prevent phase separation in oil-in-water food compositions during mixing and heat sterilization.

Chlorite solutions oxidize and destroy dysfunctional red blood cells containing glycation endproducts.

Introducing specific desaturase and elongase genes into transgenic organisms to shift fatty acid synthesis pathways.

Probiotic-mediated calcium absorption increases uptake while minimizing kidney stone risk by bypassing vitamin D dependency.

Controlled crystallization of thiadiazole DPP-IV inhibitors resolves stability and processing contradictions.

Adjusting pH below the isoelectric point with glycerin prevents gelation, enabling ready-to-use liquid delivery for bi-hormonal pumps.

Specific probiotic strains administered via enteral routes modulate gut microbiota composition, addressing inadequate obesity treatment effectiveness.

2,3-Butanediol inhibits FMO5 to reduce fat body-weight ratio and plasma cholesterol levels.

Imeglimin lowers HbA1c and fasting plasma glucose without increasing hypoglycemia risk in moderate to severe chronic kidney disease.

Senolytic agents remove senescent beta cells producing harmful SASP secretome, preventing Type 1 diabetes progression.

Flattop biomarker expression distinguishes mature beta cells from immature progenitors, enabling precise compound screening for diabetes therapies.

Covalent lactoferrin-polymer conjugates extend FGF21 half-life through receptor-mediated absorption, enabling sustained glucose regulation.

Lipid nanoparticles deliver mRNA encoding glucose-6-phosphatase to hepatocytes, restoring blood glucose homeostasis in glycogen storage disease type 1a.

Antibodies targeting PI16 resolve intracellular FoxP3 detection limits by enabling surface-based isolation of regulatory T cells.

A lentiviral vector delivers codon-optimized MMUT genes to hepatocytes for stable enzyme replacement.

Segmenting dapagliflozin and metformin into separate tablets with surfactants resolves content uniformity issues caused by large drug-to-drug ratios.